Meet the Team

Kamran Ghashghaei, CEO

With two decades of expertise spanning R&D, engineering, and quality within the life sciences, medical devices, and in vitro toxicology diagnostics industries, Kamran's passion for innovation and excellence drives his leadership in advancing critical technologies and shaping industry standards.

Prior to founding Molpure, he led the groundbreaking development of radiopharmaceutical iTLC-SG for Varian, Inc. (now an Agilent Technologies product), making a crucial contribution after its discontinuation by Pall more than a decade ago.

Today, leveraging his deep expertise, Kamran’s vision has propelled Molpure to develop its line of evolved, next-generation ITLC products—a solution manufactured through a proprietary and enhanced process. His commitment to problem-solving and process optimization continues to drive Molpure’s cutting-edge innovations.